| Literature DB >> 36130927 |
Yun-Ze Li1, Na Rao1, Lun An1, Xiao-Long Wan1, Yanxia Zhang1, Xingang Zhang2,3.
Abstract
Despite paramount applications of chiral trifluoromethylated compounds in medicinal chemistry and materials science, limited strategies have been developed for catalytic asymmetric synthesis of such valuable fluorinated structures. Here, we report a nickel catalyzed enantioselective dicarbofunctionalization of inexpensive industrial chemical 3,3,3-trifluoropropene (TFP) with readily available tertiary alkyl and aryl iodides. The reaction overcomes the β-F elimination side reaction of TFP, and proceeds efficiently under mild reaction conditions. The protocol possesses advantages, such as synthetic convenience, high enantioselectivity, and excellent functional group tolerance, providing rapid and straightforward access to chiral trifluoromethylated compounds of medicinal interest.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36130927 PMCID: PMC9492779 DOI: 10.1038/s41467-022-33159-2
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694
Fig. 1Nickel-catalyzed enantioselective dicarbofunctionalization of TFP and representative biologically active molecules bearing an α-CF3 stereogenic center.
a Biologically active molecules bearing an α-CF3 stereogenic center. b Pathways for α-CF3 metal species. c Nickel-catalyzed enantioselective dicarbofunctionalization of TFP (this work).
Representative results for the optimization of the reaction conditionsa
| Entry | Ligand | Yield (%)b | ee (%)c |
|---|---|---|---|
| 1 | 84 | – | |
| 2 | 51 | 87 | |
| 3 | 66 | 90 | |
| 4 | 72 | 69 | |
| 5 | 61 | 63 | |
| 6 | 69 | 90 | |
| 7 | 52 | 13 | |
| 8 | nd | – | |
| 9d | 74 (70) | 91 | |
| 10d,e | nd | – | |
| 11d | None | nd | – |
nd not detected, DMA dimethylacetamide, DME dimethyl ether.
aReaction conditions (unless otherwise specified): 1 (0.64 mmol, 0.54 mL, 1.2 M in DMA, 1.6 equiv), 2a (0.6 mmol, 1.5 equiv), 3a (0.4 mmol, 1.0 equiv), Zn (0.6 mmol, 1.5 equiv), 1,4-dioxane (3.2 mL).
bThe yield was determined by 19F NMR using benzotrifluoride as an internal standard, and number in parentheses is the isolated yield.
cDetermined by chiral HPLC.
dDME instead of 1,4-dioxane was used.
eWithout nickel catalyst.
Fig. 2Scope of the nickel-catalyzed enantioselective alkyl-arylation of TFP.
aConditions A (unless otherwise specified): NiBr2·DME (10 mol%), L6 (10 mol%), 1 (1.2 M in DMA, 1.6 equiv), 2 (1.5 equiv), 3 (0.4 mmol, 1.0 equiv), DME (3.2 mL). All reported yields are isolated yields. bAryl bromide or vinyl bromide was used. c0.5 equiv of NaI was used. d10 mol% DMAP, 2 (0.4 mmol, 1.0 equiv) and 3 (0.6 mmol, 1.5 equiv) were used. eNiBr2·DME (13 mol%) and L6 (13 mol%) were used. fConditions B (unless otherwise specified): NiBr2·DME (12 mol%), L6 (10 mol%), 1 (1.2 M in DMA, 1.6 equiv), 2 (1.5 equiv), 3 (0.2 mmol, 1.0 equiv), FeCl3 (0.25 equiv), DME (1.6 mL). All reported yields are isolated yields. gFeBr2 (0.25 equiv) instead of FeCl3 (0.25 equiv) was used. h0.5 equiv of NaI instead of FeCl3 (0.25 equiv) was used. iNo additive was used. DMAP, N,N-dimethylpyridin-4-amine.
Fig. 3Synthetic applications.
a Gram-scale synthesis of 4b. b Transformations of compound 5b. EDCI, (1-ethyl-3(3-dimethylpropylamine) carbodiimide.
Fig. 4Radical trapping experiments.
a Radical inhibition experiments. b Radical clock experiment. c EPR experiment.
Fig. 5Proposed reaction mechanisms.
a Possible mechanism I (path I). b Possible mechanism II (path II).